Skip to main navigation
Akero
Akero
  • Overview
  • Press Releases
  • Presentations, Events & Webcasts
  • Stock Information
  • SEC Filings
  • Corporate Governance
    • Governance Overview
    • Committee Composition
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

Contact IR

Contact IR

  • Print
  • RSS Feeds
  • Email Alerts
  • Contact IR
  • About
  • R & D
  • Efruxifermin
  • Investors
  • What is Nash?
  • Contact
© 2021 Akero Therapeutics, Inc. All rights reserved. Terms of Use.
Scroll to top